Jeffrey T Chang

24PUBLICATIONS

138CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyCancer cell biologyMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (24)

Sort by Publication Date:

|Nov 02, 2026

Early temporal transcriptional and cytokine responses distinguish chemotherapy sensitivity in patient-derived xenograft models of triple-negative breast cancer.

|Apr 03, 2026

Regulation of mitochondrial ROS by C15ORF48 in a basal cell subpopulation contributes to chemotherapy resistance in TNBC.

Yan Jiang, Noor M Abdulkareem, Amanda L Rinkenbaugh

|Aug 13, 2025

An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy.

Amanda L Rinkenbaugh, Yuan Qi, Shirong Cai

|Jun 25, 2025

Nerve-to-cancer transfer of mitochondria during cancer metastasis.

Gregory Hoover, Shila Gilbert, Olivia Curley

|May 09, 2025

Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancer.

Jason I Griffiths, Feng Chi, Elena Farmaki

|Mar 03, 2025

Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers.

Jason I Griffiths, Patrick A Cosgrove, Eric F Medina

Pageof 4

Frequent Collaborators

Helen Piwnica-Worms

Jason White

Amanda L Rinkenbaugh

Gloria V Echeverria

Andrea H Bild

Xiaomei Zhang

W Fraser Symmans

Patrick A Cosgrove

Bora Lim

Gaiane M Rauch

Frequent Collaborators

Helen Piwnica-Worms

Jason White

Amanda L Rinkenbaugh

Gloria V Echeverria